{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:35:21Z","timestamp":1753889721397},"reference-count":13,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T00:00:00Z","timestamp":1141689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> This case describes a young girl with Graves' disease, who presented with fulminant hepatic failure 9 months into propylthiouracil (PTU) therapy. Her clinical presentation was consistent with \u2018probable autoimmune hepatitis,\u2019 as defined by the International Autoimmune Hepatitis Group scoring system. Despite discontinuation of PTU and high\u2010dose steroid therapy, she required liver transplantation. Subsequent pathology could not definitively rule out autoimmune hepatitis. PTU is an important cause of drug\u2010related liver failure in children, and clinicians should be mindful that it is frequently used in patients who already have an underlying risk of autoimmune liver disease.<\/jats:p>","DOI":"10.1111\/j.1399-3046.2006.00487.x","type":"journal-article","created":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T14:33:38Z","timestamp":1141742018000},"page":"525-528","source":"Crossref","is-referenced-by-count":16,"title":["Propylthiouracil\u2010associated liver failure presenting as probable autoimmune hepatitis in a child with Graves' disease"],"prefix":"10.1111","volume":"10","author":[{"given":"Walter E. B.","family":"Sipe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Posselt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace E.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Antonio","family":"Quiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,5,19]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4412"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-35704"},{"key":"e_1_2_5_4_2","first-page":"929","article-title":"International autoimmune hepatitis group report","volume":"31","author":"Alvarez F","year":"1999","journal-title":"review of criteria for diagnosis of autoimmune hepatitis"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1997.01430330016002"},{"key":"e_1_2_5_6_2","first-page":"165","article-title":"The incidence and clinical characteristics of symptomatic propylthiouracil\u2010induced hepatic injury in patients with hyperthyroidism","volume":"96","author":"Kim HJ","year":"2001","journal-title":"a single-center retrospective study"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.10.6922"},{"key":"e_1_2_5_8_2","first-page":"845","article-title":"Propylthiouracil\u2010induced fulminant hepatitis","volume":"16","author":"Deidiker R","year":"1996","journal-title":"case report and review of the literature"},{"key":"e_1_2_5_9_2","first-page":"1727","article-title":"Fifty years of experience with propylthiouracil\u2010associated hepatotoxicity","volume":"82","author":"Williams KV","year":"1997","journal-title":"what have we learned?"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20204"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A408"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2169\/internalmedicine.42.331","article-title":"Autoimmune hepatitis associated with Graves' disease","volume":"42","author":"Cui B","year":"2003","journal-title":"Intern Med"},{"key":"e_1_2_5_13_2","first-page":"541","article-title":"Autoimmune hepatitis in childhood","volume":"25","author":"Gregorio GV","year":"1997","journal-title":"a 20-year experience"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu313cr"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3046.2006.00487.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3046.2006.00487.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T18:36:23Z","timestamp":1697308583000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3046.2006.00487.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,19]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1111\/j.1399-3046.2006.00487.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3046.2006.00487.x","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,19]]}}}